(Q30856729)

18 August 2017

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? (English)

1 reference

18 August 2017

1 reference

1 reference

Dara O Kavanagh

1

1 reference

18 August 2017

Gillian Chambers

2

1 reference

18 August 2017

Liam O'Grady

3

1 reference

18 August 2017

Kevin M Barry

4

1 reference

18 August 2017

Ronan P Waldron

5

1 reference

18 August 2017

Fadel Bennani

6

1 reference

18 August 2017

Paul W Eustace

7

1 reference

18 August 2017

Iqdam Tobbia

8

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

1

1 reference

Creative Commons Attribution 2.0 Generic

18 August 2017

start time

1 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-1

0 references

cites work

HER 2/neu protein expression in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

HER-2/neu evaluation in breast cancer are we there yet?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

28 July 2018

Cancer statistics, 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

c-erbB-2 is not a major factor in the development of colorectal cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

The ErbB signaling network: receptor heterodimerization in development and cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648993

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-1

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-1

The HER-2/neu oncogene in tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-1

HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-1

HER 2/neu expression and gene amplification in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-1

Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-1

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-1

Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer

21 January 2018

1 reference

12 December 2020

The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer

1 reference

12 December 2020

Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival

1 reference

12 December 2020

HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors

1 reference

12 December 2020

Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-9-1

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

1 reference